iCrowdNewswire Feb 22, 2021 7:00 PM ET
Global Cardiology Surgery, Devices and Drugs Industry
The global cardiology devices & drugs market is expected to grow at a CAGR of 7.4% for the forecasted period of 2018-2023. The report covers three major segments of interventional cardiology market which include surgeries, devices, and drugs. As per WHO more than 17 million people died due to CVD in 2015 which makes is the number one cause of death globally. Some of the major CVDs include coronary heart diseases, stroke, hypertensive heart diseases, inflammatory heart diseases, rheumatoid heart diseases and others. Coronary heart diseases are the leading cause of death followed by strokes. The prevalence and incidence rate of heart diseases are on a rise; especially in major emerging countries such as India, China, and Japan. The market of cardiology surgery, devices and drugs are also on a rise.
One of the major factors driving the market is medical tourism. Especially in emerging markets such as India, ASEAN countries and China, the cost of surgery and treatment for cardiovascular diseases is low. In India, a heart surgery costs around $1,500 whereas in the United States it costs 5 to 10 times more than India. Hence, many Americans prefer to travel to India for their treatment.
North America is the leading market with highest market share. The market is expected to grow at a CAGR of 6.8 percent. North American marker is followed by Europe, Asia-Pacific and Rest of the world. Asia Pacific market is expected to have highest CAGR of 9.5% for the forecasted period of 2018-2023.
Key companies profiled in the report includes Pfizer, Sanofi, AstraZeneca, Novartis, Bristol-Myers Squibb, Merck, Boston Scientific Corp., Medtronic, Sun Pharma, Roche Bayer and others.
The Market Segmentation includes:
Cardiology Drugs Market by Indications
Cardiology Drugs Market by Mechanism of Action
The Report Covers:
Comprehensive research methodology of Global cardiology surgery devices drugs market
In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global cardiology surgery devices drugs market.
Insights about market determinants which are stimulating the Global Interventional Cardiology Surgery, Devices and Drugs market
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players
For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3204445-global-cardiology-surgery-devices-and-drugs-market-research-and-forecast-2018-2023
Some points from table of content:
- REPORT SUMMARY
- MARKET OVERVIEW AND INSIGHTS
- MARKET DETERMINANT
- MARKET SEGMENTATION
- COMPETITIVE LANDSCAPE
- REGIONAL ANALYSIS
- COMPANY PROFILES (COMPANY OVERVIEW, PRODUCT PORTFOLIO, RECENT DEVELOPMENTS, REVENUE ANALYSIS)
For more information or any query mail at [email protected]
About the Author:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.
Keywords: global Cardiology Surgery, Devices and Drugs market, Cardiology Surgery, Devices and Drugs reports, Cardiology Surgery, Devices and Drugs market, Cardiology Surgery, Devices and Drugs research, Cardiology Surgery, Devices and Drugs industry, Cardiology Surgery, Devices and Drugs trends, Cardiology Surgery, Devices and Drugs forecast